News_News_COSYCHEM

12/02/2021

The COVID-19 detection concept is making a comeback! IVD may break out

Recently, COVID-19 mutant (Omicron) was discovered in southern Africa, and then spread rapidly in South Africa and around the world. The mutant has more mutations and faster transmission than delta virus, which has attracted much attention in the world. The vaccine giant Moderna CEO predicted that the existing vaccine would be far less effective than the early COVID-19 in dealing with it, and that large scale production of the new vaccine may take months. Under the background that the protective effect of vaccine may decline, it may be the most effective epidemic prevention method to isolate timely the source of infection through COVID-19 detection. Therefore, the support of COVID-19 detection reagent is indispensable for epidemic resistance at home and abroad. The implementation of home testing at home and abroad has also imperceptibly changed people's understanding and consumption concept of testing products. It indicates that in vitro diagnosis (IVD), especially Point-Of-CareTesting (POCT) in the subdivided field of IVD, will enter thousands of households gradually in the future. This has greatly promoted the trend of building an ecological closed loop of IVD and daily life health management in the industry. And this change will take place on a global field. POCT is the future trend of IVD industry What is POCT? What is the difference and relationship between it and IVD? There are many kinds of IVD products which are mainly used in hospitals. However, the traditional IVD products are not convenient and even can’t be used in many scenarios where medical personnel is absent, such as policeman checking drunk-driving, the home blood glucose test, and the health status detect of visitors at the customs. A new IVD equipment is required. It may not be able to meet the needs of the rapid detection of hundreds of products at one time by high-level equipment in the high-speed inspection center. On the contrary, it will reached the other end: the equipment is very small and there are not many items that can be tested at one time. This is a popular product in the IVD industry recently, called POCT. Its full English name is Point-Of-CareTesting. POCT is a rapidly developing subdivision field in the world. According to the Global POCT Outlook report, the global market size in 2018 was about US $24 billion, with a compound growth rate of more than 8% from 2013 to 2018. Among them, except for the blood glucose monitoring market, which accounts for a large proportion of the POCT market, the growth rate of several other segments maintained a high growth rate of more than 10%. The world POCT market is mainly concentrated in the United States and Europe. It is expected that the size of the POCT market will exceed US $27 billion in 2020. The share of Asia Pacific POCT market in the global market is expected to continue to increase. According to BCC Research data, in 2018, the market scale of POCT in the Asia Pacific region was about US $5 billion, accounting for about 25% of the global market share; It is estimated that the Asia Pacific POCT market will exceed US $8 billion by 2023, accounting for 34% of the world. At present, according to the statistics of relevant institutions, the penetration rate of IVD in China is significantly lower than that in developed countries. The penetration rate of POCT in developed countries such as Britain, America, Germany, France and Canada is generally about 30%, and it is still on the rise. In 2018, the penetration rate of POCT in the United States was about 30%, which is expected to grow steadily in the future and reach about 36% by 2023. According to Frost & Sullivan data, the penetration rate of China's POCT in 2018 was about 14.7%, lower than half of that of the United States. In the next five years, China's POCT market is expected to grow rapidly at the rate of 20% - 25%, and the penetration rate of China's POCT market to IVD will grow fastest in the world. In 2023, the penetration rate of POCT to IVD will increase most significantly, and will reach about 20% in 2023. Source: Securities Star

View Article →

The COVID-19 detection concept is making a comeback! IVD may break out

View Article →

10/27/2021

Warmly congratulate our company on completing the round A financing of nearly 100 million yuan and building a domestic leading CDMO platform for small molecular drugs + IVD raw materials

On October 27, 2021, Official announcement issued by our company: Cosychem Technology (Tianjin) Co., Ltd. (Abbreviation: Cosychem) completed A round of financing of nearly 100 million yuan, led by Tianchuang capital, followed by Bozheng capital and Xinghan capital as the exclusive financial consultant. This round of financing will be mainly used for the construction of the company's production base and the R & D of new products, While consolidating the CDMO business of small molecule innovative drugs, it will further accelerate the production and transformation of core raw material business in the field of IVD. This financing is the first external financing of our company. In the development process of the first 10 years, Cosychem has completed the growth of output value from 0 to 100 million yuan by relying on its independent growth ability, and its business has gradually expanded from early CRO service to CDMO business. In the field of small molecule CDMO with relatively fierce competition, relying on years of experience in chemical synthesis and production amplification, our company has become the core supplier of many leading pharmaceutical enterprises. In 2013, our company began to layout IVD raw materials and successfully developed several key IVD raw material products such as dNTP and fluorescent probe. Our company will also further deepen the construction of R & D platform with the support of this financing. "In the past, the company focused on technology R & D services, and most of the orders were customized products with high added value but less volume. In the future, the company will focus on large-scale production of key technical achievements, create products with market leading position, provide one-stop services from R & D to production, and establish the Cosychem brand to realize early intervention and deep binding of the innovative pharmaceutical projects We will keep the key core technologies in our own hands and make continuous efforts for the rapid and stable development of biomedicine." Mr Yanmin Song, founder of the company, said.

View Article →

Warmly congratulate our company on completing the round A financing of nearly 100 million yuan and building a domestic leading CDMO platform for small molecular drugs + IVD raw materials

View Article →

10/27/2021

Celebration: the 11th anniversary of Cosychem company

On October 27, 2021, Cosychem Technology (Tianjin) Co., Ltd. celebrated its eleventh anniversary! Looking back on the journey, these eleven years are a history of Cosychem's entrepreneurship, struggle, take-off，reform and innovation, which deduces the stormy process of Cosychem's people going all out, daring to take responsibility, daring to challenge and forge ahead. In 2021, Cosychem company determined the third five-year strategic plan, completed the first round of 100 million yuan financing, and comprehensively upgraded its infrastructure and corporate culture. Thank you for walking all the way Thank you for your efforts for the development of Cosychem! We, who escort the growth of Cosychem, are lucky to have you! For the glory of Cosychem, everyone who will join us soon, look forward to you! Celebration: Happy 11th birthday to Cosychem! Congratulate: Cosychem has completed the first round of financing and started a new journey! Wish: forge ahead and create the future together!

View Article →

Celebration: the 11th anniversary of Cosychem company

View Article →

10/22/2021

Cosychem's new logo goes online and starts from a new starting point

Enterprise logo is an important part of the enterprise culture system, an important way for the audience to form a good perception of the enterprise, and also an important support and carrier of the enterprise brand image. In recent years, with the major adjustment of the enterprise development strategy and the profound change of the management system, the enterprise reform and development has opened a new journey. In order to further improve the company's image and shape the industry brand, the company has comprehensively optimized and improved the old logo. The overall style of the new logo: simple, modern, scientific and international. The whole figure is a two-color regular hexagon design. The regular hexagon connects from the center to each fixed point as an equilateral triangle, which is the most stable and symmetrical shape; The hexagon is between the square and the circle as a whole, which has the meaning of "Six Harmonies", matches the company's concept of "Going all out, Harmonious coexistence, Integrity and win-win", and reflects the company's development concept and industry characteristics. The graph is divided into two parts, which is a combination of two hands, expressing the communication and cooperation between enterprises and customers, and integrating the C & C concept extracted from brand name and positioning. Font design has a sense of science and technology and professionalism, with specificity and coordination with graphics. The logo color selects two kinds of blue, dark blue, profound technology, to express the infinite possibility of science; Light blue is lively and young, implying the vitality and vitality of the company. The replacement of our new logo is not only an innovation of brand image, but also a new start. We will always adhere to the concept of "Going all out, Harmonious coexistence, Integrity and win-win", continue to devote ourselves to R & D and production of high-tech products, constantly optimize customer service, and promote the development of the pharmaceutical industry with innovative scientific and technological achievements.

View Article →

07/09/2021

Warmly congratulate our company on successfully passing the evaluation of the integration management system of informatization and industrialization

On July 9, 2021, our company successfully obtained the "evaluation certificate of the integration management system of informatization and industrialization" (Certificate No.: AIITRE-00721IIIMS0095201), which indicates that our company has stepped to a new level in the integration management of informatization and industrialization. The integration of informatization and industrialization is a high-level and in-depth combination of informatization and industrialization. It refers to driving industrialization with informatization, promoting informatization with industrialization, and taking a new road of industrialization. In order to improve the company's information support and keep up with the pace of the information age, our company actively promotes the construction of the "integration of informatization and industrialization " management system around the integration management activities related to the construction of order rapid delivery capacity of R & D products. In the process of construction, the company applies informatization to the whole process of enterprise R & D management, forming a set of effective and stable management system, which not only improves the work efficiency of employees, reduces R & D costs, but also improves the competitive advantage of the company's sustainable development. Through this evaluation, our company deeply realizes that the integration of informatization and industrialization is a major measure for enterprise technological transformation and management innovation, which plays a significant role in improving the overall quality and core competitiveness of the enterprise and realizing scientific management. Our company will take the integration management system certification of informatization and industrialization as an opportunity to further improve the in-depth combination of enterprise informatization and industrialization, and help the improvement of enterprise management and innovative development.

View Article →

Warmly congratulate our company on successfully passing the evaluation of the integration management system of informatization and industrialization

View Article →